Schedule 13D ownership disclosure

ENZON INC

Common Stock, No par value · CUSIP: 293904108

Event date: 2024-12-19

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • CARL C ICAHNReported CIK 0000921669

    Shares: 36,056,636.00 · Class: 48.6%

  • ICAHN PARTNERS MASTER FUND LPReported CIK 0001322827

    Shares: 14,923,911.00 · Class: 20.1%

  • Icahn Offshore LPReported CIK 0001322825

    Shares: 14,923,911.00 · Class: 20.1%

  • Icahn Partners LPReported CIK 0001313666

    Shares: 21,132,725.00 · Class: 28.5%

  • Icahn Onshore LPReported CIK 0001322826

    Shares: 21,132,725.00 · Class: 28.5%

  • Icahn Capital LPReported CIK 0001412093

    Shares: 36,056,636.00 · Class: 48.6%

  • IPH GP LLCReported CIK 0001412091

    Shares: 36,056,636.00 · Class: 48.6%

  • ICAHN ENTERPRISES HOLDINGS L.P.Reported CIK 0001034563

    Shares: 36,056,636.00 · Class: 48.6%

  • ICAHN ENTERPRISES G.P. INC.Reported CIK 0001257324

    Shares: 36,056,636.00 · Class: 48.6%

  • BECKTON CORPReported CIK 0001080113

    Shares: 36,056,636.00 · Class: 48.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-130184
Form type
SCHEDULE 13D/A
Filer
ENZON PHARMACEUTICALS, INC.
CIK
CIK 727510
Filed
Dec 19, 2024
Reporting period
Dec 19, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub